Overview
- Focuses on carbonic anhydrases as potential therapeutic targets
- Covers clinical disciplines such as oncology, neurology, ophthalmology, and metabolic, vascular and pulmonary medicine
- Ensures its value to a broad readership through the comprehensive, inter-disciplinary nature of the text
Part of the book series: Progress in Drug Research (PDR, volume 75)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (12 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
This volume assembles and integrates the wealth of diverse information that is now accumulating in this burgeoning field. The existing and potential therapeutic applications of targeting CA cover a remarkably wide-range of diseases and disorders and have generated increasing and extensive interest in recent years. Its inter-disciplinary approach embraces both the most up-to-date therapeutic application of CA-targeting and the latest research data that will provide a platform for the development of novel applications. The interested audience comprises scientists and clinicians from many relevant disciplines within science and medicine.
Editors and Affiliations
Bibliographic Information
Book Title: The Carbonic Anhydrases: Current and Emerging Therapeutic Targets
Editors: W. Richard Chegwidden, Nicholas D. Carter
Series Title: Progress in Drug Research
DOI: https://doi.org/10.1007/978-3-030-79511-5
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Nature Switzerland AG 2021
Hardcover ISBN: 978-3-030-79510-8Published: 31 October 2021
Softcover ISBN: 978-3-030-79513-9Published: 31 October 2022
eBook ISBN: 978-3-030-79511-5Published: 30 October 2021
Series ISSN: 0071-786X
Series E-ISSN: 2297-4555
Edition Number: 1
Number of Pages: XII, 288
Number of Illustrations: 16 b/w illustrations, 22 illustrations in colour
Topics: Pharmacology/Toxicology, Medical Biochemistry, Pharmacy